Nanobots Therapeutics
PrivateLast Round
Seed
Dec 18, 2024
Est. Valuation
$7.81M
Total Funding Raised
$2.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Nanobots Therapeutics operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a Seed round in December 2024.
Nanobots Therapeutics is a biotechnology company developing a nanorobot-based drug delivery platform, MotionTx, to deliver treatments directly to target tissues, with an initial focus on bladder cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanobots Therapeutics Comparables
Compare Nanobots Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoDrug Delivery GmbH | 81% | |
| Bionaut Labs | 77% | |
| Onselex Pharmaceuticals | 75% |
For institutional investors. Book with your work email.
Nanobots Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 18, 2024 | ||||
| Pre Seed | Sep 22, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nanobots Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACCIÓ - Agency for Business Competitiveness | Pre Seed, Seed |
| Agencia Estatal de Investigación | Seed |
| Prous Institute for Biomedical Research | Pre Seed, Seed |
| BStartup Health | Seed, Pre Seed |
| Chasing Science | Pre Seed |
| BStartup Banco Sabadell | Pre Seed |
| Spanish Association Against Cancer | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Open roles increased to 6, representing 40% of headcount.
- Jul 28, 2026
Monthly visitors increased 94% MoM.
For institutional investors. Book with your work email.
Nanobots Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nanobots Therapeutics's valuation, stock price, and market status.
Is Nanobots Therapeutics a public or private company?
Nanobots Therapeutics is a private company.
What is the current stock price of Nanobots Therapeutics?
Nanobots Therapeutics is a private company, so its shares have no public market price. Caplight tracks Nanobots Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanobots Therapeutics worth (valuation)?
Nanobots Therapeutics's valuation is estimated at $7.8M based on funding round data.
Can I buy Nanobots Therapeutics stock?
Nanobots Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanobots Therapeutics's last funding round?
Nanobots Therapeutics's most recent funding round was Seed on December 18, 2024.
Who are the main investors in Nanobots Therapeutics?
Key investors in Nanobots Therapeutics include BStartup Health, BStartup Banco Sabadell.
Will Nanobots Therapeutics IPO soon?
No public IPO plans have been announced for Nanobots Therapeutics.
How can I track Nanobots Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Nanobots Therapeutics's shares on secondary markets.